Informazioni sul prodotto
Nome:
N-(2-Carboxycaproyl)hydrazobenzene
Sinonimi:
- 2-(2,3-Diphenylcarbazoyl)hexansaeure
- B 64114
- Brn 0696638
- Bumadizon
- Bumadizona
- Bumadizona [INN-Spanish]
- Bumadizone [INN:DCF]
- Bumadizonum
- Bumadizonum [INN-Latin]
- Butylmalonic acid mono(1,2-diphenylhydrazide)
- Vedi altri sinonimi
- Malonic acid, butyl-, 1,2-diphenylhydrazide
- Malonic acid, butyl-, mono(1,2-diphenylhydrazide)
- Propanedioic acid, 2-butyl-, 1-(1,2-diphenylhydrazide)
- Propanedioic acid, butyl-, mono(1,2-diphenylhydrazide)
- Propanedioic acid, butyl-, mono(1,2-diphenylhydrazide) (9CI)
- Unii-Atd81G944M
- n-Butylmalonic acid N,N'-diphenylhydrazide
- Bumadizone
Descrizione:
N-(2-Carboxycaproyl)hydrazobenzene is an anti-infective agent that is used to treat inflammatory bowel disease. It inhibits the effector proteins of proinflammatory cytokines, has a calcium binding and enzyme inhibitory activity, and is biocompatible with human serum. N-(2-Carboxycaproyl)hydrazobenzene is also effective against bacteria such as Escherichia coli and Salmonella enterica, and fungi such as Candida albicans. This drug can also be used to treat autoimmune diseases such as rheumatoid arthritis or Crohn's disease. N-(2-Carboxycaproyl)hydrazobenzene can be administered orally or topically depending on the severity of the condition.
Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:
Proprietà chimiche
Peso molecolare:
326.39 g/mol
Formula:
C19H22N2O3
Purezza:
Min. 95%
MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:
